Related Experiment Video
Updated: Mar 25, 2026
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
SALL4, the missing link between stem cells, development and cancer
Hiro Tatetsu1, Nikki R Kong1, Gao Chong1
1Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, New Research Building Room 652D, Boston, MA 02115, USA.
Abstract:
There is a growing body of evidence supporting that cancer cells share many similarities with embryonic stem cells (ESCs). For example, aggressive cancers and ESCs share a common gene expression signature that includes hundreds of genes. Since ESC genes are not present in most adult tissues, they could be ideal candidate targets for cancer-specific diagnosis and treatment. This is an exciting cancer-targeting model. The major hurdle to test this model is to identify the key factors/pathway(s) within ESCs that are responsible for the cancer phenotype. SALL4 is one of few genes that can establish this link. The first publication of SALL4 is on its mutation in a human inherited disorder with multiple developmental defects. Since then, over 300 papers have been published on various aspects of this gene in stem cells, development, and cancers. This review aims to summarize our current knowledge of SALL4, including a SALL4-based approach to classify and target cancers. Many questions about this important gene still remain unanswered, specifically, on how this gene regulates cell fates at a molecular level. Understanding SALL4's molecular functions will allow development of specific targeted approaches in the future.
Insights
Cancer cells resemble embryonic stem cells (ESCs), sharing gene expression patterns. SALL4 is a key gene linking ESCs and cancer, offering potential for targeted cancer diagnosis and treatment.
Area of Science:
- Oncology
- Stem Cell Biology
- Molecular Biology
Background:
- Cancer cells exhibit similarities to embryonic stem cells (ESCs), including shared gene expression signatures.
- ESC-specific genes present potential targets for cancer diagnosis and therapy due to their absence in most adult tissues.
- Identifying key embryonic stem cell factors driving the cancer phenotype is crucial for developing targeted treatments.
Purpose of the Study:
- To review the current understanding of the SALL4 gene in relation to stem cells, development, and cancer.
- To explore a SALL4-based strategy for classifying and targeting cancers.
- To highlight unanswered questions regarding SALL4's molecular functions in cell fate regulation.
Main Methods:
- Literature review of SALL4 research in stem cells, development, and cancer.
- Analysis of SALL4's role in establishing links between embryonic stem cells and cancer.
- Synthesis of knowledge on SALL4's function and potential therapeutic applications.
Main Results:
- SALL4 is identified as a key gene connecting embryonic stem cells and cancer phenotypes.
- Over 300 publications demonstrate SALL4's involvement in stem cells, development, and various cancers.
- A SALL4-based approach for cancer classification and targeting is proposed.
Conclusions:
- SALL4 plays a significant role in linking embryonic stem cells and cancer.
- Further research into SALL4's molecular mechanisms is essential for developing targeted cancer therapies.
- Understanding SALL4's regulation of cell fate holds promise for future cancer treatment strategies.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
01:01Regulation of Hematopoietic Stem Cells
01:19Multipotency of Hematopoietic Stem Cells
01:29Somatic to iPS Cell Reprogramming